ICU Medical Inc

ICUI

Company Profile

  • Business description

    ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

  • Contact

    951 Calle Amanecer
    San ClementeCA92673
    USA

    T: +1 949 366-2183

    E: [email protected]

    https://www.icumed.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2025

    Employees

    15,000

Stocks News & Analysis

stocks

Materially undervalued ASX tech share

Long reinvestment runway supports our thesis on ASX technology company.
stocks

For US software stocks, it’s been an AI bust, not a boom

Once-hot software names are lagging. Are they good buys?
stocks

Finding value in the Aussie mining sector

Is the mining sector overvalued? A new Morningstar report highlights pockets of value that remain.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,812.9030.50-0.34%
CAC 407,959.6722.98-0.29%
DAX 4023,239.18147.310.64%
Dow JONES (US)46,448.27202.860.44%
FTSE 1009,534.914.80-0.05%
HKSE25,875.36158.860.62%
NASDAQ22,872.01598.922.69%
Nikkei 22548,710.7084.820.17%
NZX 50 Index13,480.4319.42-0.14%
S&P 5006,705.12102.131.55%
S&P/ASX 2008,525.8037.90-0.44%
SSE Composite Index3,880.2243.451.13%

Market Movers